Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years
Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 20 years by 15.96% on an annualized basis producing an average annual return of 23.84%. Currently, Regeneron Pharmaceuticals has a market capitalization of $100.69 billion.
在過去的20年中，Regeneron Pharmicals（納斯達克股票代碼：REGN）的年化表現比市場高出15.96％，平均年回報率爲23.84％。目前，Regeneron Pharmicals的市值爲1006.9億美元。
Buying $100 In REGN: If an investor had bought $100 of REGN stock 20 years ago, it would be worth $7,527.35 today based on a price of $913.82 for REGN at the time of writing.
購買100美元的REGN：如果投資者在20年前購買了100美元的REGN股票，那麼根據撰寫本文時REGN的913.82美元價格，今天的價值將達到7,527.35美元。
Regeneron Pharmaceuticals's Performance Over Last 20 Years
Regeneron Pharmicals在過去20年中的表現
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
最後，這一切的意義何在？從本文中得出的關鍵見解是，在一段時間內，複合回報可以對您的現金增長產生多大的影響。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。
譯文內容由第三人軟體翻譯。